These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

613 related items for PubMed ID: 16771722

  • 1. Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003).
    Shigemura K, Arakawa S, Sakai Y, Kinoshita S, Tanaka K, Fujisawa M.
    Int J Urol; 2006 May; 13(5):538-42. PubMed ID: 16771722
    [Abstract] [Full Text] [Related]

  • 2. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment.
    Marcus N, Ashkenazi S, Samra Z, Cohen A, Livni G.
    Infection; 2008 Oct; 36(5):421-6. PubMed ID: 18795227
    [Abstract] [Full Text] [Related]

  • 3. [Clinical study of Pseudomonas aeruginosa isolated from the urine of patients with urinary tract infections].
    Shimura S, Inaba K, Ikeda S, Ishibashi A, Hirata Y, Osawa N.
    Hinyokika Kiyo; 1992 Jan; 38(1):37-41. PubMed ID: 1546567
    [Abstract] [Full Text] [Related]

  • 4. Pathogen occurrence and antimicrobial susceptibility of urinary tract infection cases during a 20-year period (1983-2002) at a single institution in Japan.
    Shigemura K, Tanaka K, Okada H, Nakano Y, Kinoshita S, Gotoh A, Arakawa S, Fujisawa M.
    Jpn J Infect Dis; 2005 Oct; 58(5):303-8. PubMed ID: 16249626
    [Abstract] [Full Text] [Related]

  • 5. [Urinary tract infections].
    Arakawa S.
    Nihon Rinsho; 2002 Nov; 60(11):2200-3. PubMed ID: 12440130
    [Abstract] [Full Text] [Related]

  • 6. [Double-blind comparative clinical study of cefpiramide (SM-1652) and cefsulodin on complicated urinary tract infections due to P. aeruginosa].
    Kawamura N, Ohkoshi M, Okada K, Kumamoto Y, Miyamoto S, Niijima T, Kishi Y, Nishimura Y, Saito I, Yuge J.
    Hinyokika Kiyo; 1983 Sep; 29(9):1147-88. PubMed ID: 6375316
    [Abstract] [Full Text] [Related]

  • 7. Pseudomonas aeruginosa and long-term indwelling bladder catheters.
    Stickler DJ, Clayton CL, Harber MJ, Chawla JC.
    Arch Phys Med Rehabil; 1988 Jan; 69(1):25-8. PubMed ID: 3122709
    [Abstract] [Full Text] [Related]

  • 8. [Pseudomonas aeruginosa as a cause of urinary tract infections].
    Brantsaeter AB, Natås OB.
    Tidsskr Nor Laegeforen; 1994 Feb 20; 114(5):572-4. PubMed ID: 8209341
    [Abstract] [Full Text] [Related]

  • 9. Antimicrobial susceptibilities and clinical characterization of Pseudomonas aeruginosa isolates from urinary tract infections.
    Zhang X, Niu S, Zhang L.
    Urol Int; 2014 Feb 20; 93(4):464-9. PubMed ID: 24642393
    [Abstract] [Full Text] [Related]

  • 10. Types of urethral catheters for management of short-term voiding problems in hospitalized adults: a short version Cochrane review.
    Schumm K, Lam TB.
    Neurourol Urodyn; 2008 Feb 20; 27(8):738-46. PubMed ID: 18951451
    [Abstract] [Full Text] [Related]

  • 11. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN, Micek ST, Reichley RM, Ritchie DJ.
    Clin Ther; 2009 Feb 20; 31(2):299-310. PubMed ID: 19302902
    [Abstract] [Full Text] [Related]

  • 12. [Etiologic agents and risk factors in nosocomial urinary tract infections].
    Akkoyun S, Kuloğlu F, Tokuç B.
    Mikrobiyol Bul; 2008 Apr 20; 42(2):245-54. PubMed ID: 18697422
    [Abstract] [Full Text] [Related]

  • 13. Iron dictates the virulence of Pseudomonas aeruginosa in urinary tract infections.
    Mittal R, Sharma S, Chhibber S, Harjai K.
    J Biomed Sci; 2008 Nov 20; 15(6):731-41. PubMed ID: 18688758
    [Abstract] [Full Text] [Related]

  • 14. [In vitro sensitivity of 39 strains of Pseudomonas aeruginosa isolated from urine culture of hospitalized patients].
    Vanni M, Zucca C.
    Minerva Med; 1986 Jun 30; 77(27):1289-92. PubMed ID: 3088493
    [Abstract] [Full Text] [Related]

  • 15. [Use of kasugamycin in urinary tract infection, especially against Pseudomonas aeruginosa].
    Tada S, Hakamada T, Mori O, Yamazaki Y.
    Hinyokika Kiyo; 1968 Jan 30; 14(1):50-6. PubMed ID: 4971183
    [No Abstract] [Full Text] [Related]

  • 16. [Concomitant therapy with cefmenoxime and cefsulodin for refractory complicated urinary tract infection (especially caused by Pseudomonas aeruginosa)].
    Ishigami J, Fujii A, Harada M, Arakawa S, Umezu K, Kawabata G, Kataoka N, Kamidono S, Miyazaki S, Takasaki N.
    Hinyokika Kiyo; 1986 May 30; 32(5):779-88. PubMed ID: 3463188
    [Abstract] [Full Text] [Related]

  • 17. Piperacillin/tazobactam-heteroresistant Pseudomonas aeruginosa from urinary infection, successfully treated by piperacillin/tazobactam.
    Pournaras S, Ikonomidis A, Neou E, Kantzanou M, Maniatis AN, Tsakris A.
    J Antimicrob Chemother; 2008 Mar 30; 61(3):757-8. PubMed ID: 18199562
    [No Abstract] [Full Text] [Related]

  • 18. Catheter associated urinary tract infections in neurology and neurosurgical units.
    Puri J, Mishra B, Mal A, Murthy NS, Thakur A, Dogra V, Singh D.
    J Infect; 2002 Apr 30; 44(3):171-5. PubMed ID: 12099744
    [Abstract] [Full Text] [Related]

  • 19. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran.
    Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A.
    Int J Infect Dis; 2009 Mar 30; 13(2):140-4. PubMed ID: 18703368
    [Abstract] [Full Text] [Related]

  • 20. Genotypic and phenotypic characterization of Pseudomonas aeruginosa isolates from urinary tract infections.
    Tielen P, Narten M, Rosin N, Biegler I, Haddad I, Hogardt M, Neubauer R, Schobert M, Wiehlmann L, Jahn D.
    Int J Med Microbiol; 2011 Apr 30; 301(4):282-92. PubMed ID: 21193347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.